38 studies found for:    eisai alzheimer's
Show Display Options
Rank Status Study
1 Completed
Has Results
Open-Label Extension Study of 23 mg Donepezil SR in Patients With Moderate to Severe Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: 23 mg SR in Study 326;   Drug: 10 mg IR in Study 326
2 Completed
Has Results
Comparison of 23 mg Donepezil Sustained Release (SR) to 10 mg Donepezil Immediate Release (IR) in Patients With Moderate to Severe Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Aricept (donepezil SR 23 mg);   Drug: Aricept (donepezil IR 10 mg)
3 Recruiting A Study to Evaluate Safety, Tolerability, and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: BAN2401 2.5 mg/kg;   Drug: BAN2401 5.0 mg/kg;   Drug: BAN2401 10 mg/kg
4 Completed Efficacy and Safety of Aricept in the Treatment of Severe Alzheimer's Disease
Conditions: Alzheimer's Disease;   Dementia
Intervention: Drug: Donepezil hydrochloride
5 Completed A Randomized, Double-blind, Placebo-controlled, Combined Single Ascending Dose and Multiple Ascending Dose Study
Condition: Alzheimer's Disease
Interventions: Drug: Active Comparator: A;   Drug: Placebo Comparator B;   Drug: Active Comparator B;   Drug: Placebo Comparator A
6 Recruiting Dose-Finding Study To Evaluate Safety, Tolerability, and Efficacy of E2609 in Subjects With Mild Cognitive Impairment Due to Alzheimer's Disease (Prodromal Alzheimer's Disease) and Mild to Moderate Dementia Due to Alzheimer's Disease
Conditions: Alzheimer Disease;   Dementia, Alzheimer Type
Interventions: Drug: E2609;   Drug: Placebo
7 Completed
Has Results
The Clinical Response of Choline Acetyltransferase and Apolipoprotein Epsilon Gene Polymorphisms to Donepezil in Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: Donepezil
8 Completed EARTH 413: A Study of Aricept in Hispanic Patients With Mild to Moderate Alzheimer's Disease (AD)
Condition: Alzheimer's Disease
Intervention: Drug: Aricept
9 Completed The Effectiveness And Safety Of Donepezil Hydrochloride (E2020) In Subjects With Mild To Severe Alzheimer's Disease Residing In An Assisted Living Facility
Condition: Mild to Severe Alzheimer's Disease
Intervention: Drug: Donepezil HCl
10 Active, not recruiting Post-marketing Surveillance of Donepezil Hydrochloride -Investigation of the Clinical Safety and Effectiveness in Patients With Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: donepezil hydrochloride
11 Completed A 24-weeks, Multi-center, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Donepezil Hydrochloride in Chinese Subjects With Severe Alzheimer's Disease
Condition: Alzheimer's Type Dementia
Interventions: Drug: E2020;   Drug: Placebo
12 Completed
Has Results
A Study Versus E2020 10mg Followed by an Open-label Extension Phase to Explore the Safety of E2020 SR 23 mg in Japanese Subjects With Severe Alzheimer's Type Dementia
Condition: Alzheimer's Type Dementia
Intervention: Drug: E2020
13 Active, not recruiting Compare the Efficacy and Safety of Donepezil Hydrochloride 23 mg Treatment With Continuation of Donepezil Hydrochloride 10 mg Treatment in Japanese Subjects With Severe Alzheimer's Disease
Condition: Alzheimer's Type Dementia
Intervention: Drug: E2020
14 Active, not recruiting Post-marketing Surveillance of Donepezil Hydrochloride -Investigation of the Factors That Affect Aricept Medication Persistence Rate and the Safety and Efficacy in Patients With Alzheimer's Disease in Clinical Practice
Condition: Alzheimer's Disease
Intervention: Drug: Donepezil Hydrochloride
15 Completed Alzheimer's Disease Long-term Follow-up Study (ALF Study)
Condition: Alzheimer's Disease
Intervention: Drug: Donepezil Hydrochloride
16 Active, not recruiting Post-marketing Surveillance of Long-term Administration of Donepezil Hydrochloride -Investigation of the Clinical Condition and Safety in Patients With Alzheimer's Disease-
Condition: Alzheimer's Disease
Intervention: Drug: donepezil hydrochloride
17 Completed Rasagiline 1 mg and 2 mg Added to Aricept 10 mg Daily in Patients With Mild to Moderate Alzheimer's Disease (AD)
Conditions: Dementia;   Alzheimer's Disease
Intervention: Drug: Rasagiline
18 Completed Hippocampus Study: Comparative Effect of Donepezil 10mg/d and Placebo on Clinical and Radiological Markers
Condition: Alzheimer's Disease
Interventions: Drug: Experimental 1;   Drug: Placebo Comparator
19 Terminated Correlation Between Regional Brain Volume and Response to Donepezil Treatment in AD Patients
Condition: Alzheimer's Disease
Intervention: Drug: DONEPEZIL HYDROCHLORIDE
20 Recruiting A Plan on Investigation and Collection of Aricept Safety Information With a Dose Increase on Alzheimer's Disease Patients
Condition: Alzheimer's Disease
Intervention: Drug: Aricept

   Previous Page Studies Shown (1-20) Next Page (21-38) Show next page of results    Last Page
Indicates status has not been verified in more than two years